<DOC>
	<DOCNO>NCT01922089</DOCNO>
	<brief_summary>The purpose study assess safety tolerability initiate LCZ696 heart failure patient reduce ejection fraction ( HF-rEF ) use conservative ( reach target dose 6 week ) condense ( reach target dose 3 week ) up-titration regimen .</brief_summary>
	<brief_title>Safety Tolerability Initiating LCZ696 Heart Failure Patients</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>LCZ 696</mesh_term>
	<criteria>Age ≥ 18 year ; CHF New York Heart Association class IIIV ; leave ventricular ejection fraction ≤ 35 % ; beta blocker Potassium &gt; 5.2 mmol/l ; estimate glomerular filtration rate &lt; 30 ml/min/1.73 m2 ; systolic blood pressure &lt; 100 mmHg &gt; 180 mmHg ; history intolerance recommend target dos angiotensin convert enzyme inhibitor angiotensin receptor blocker Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Heart failure , reduce ejection fraction , LCZ696 , titration , safety , tolerability</keyword>
</DOC>